Evidence map›Paper›PMID 35818337›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2023

Both Disease Activity and HLA-B27 Status Are Associated With Gut Microbiome Dysbiosis in Spondyloarthritis Patients.

Magali Berland, Victoria Meslier, Samar Berreira Ibraim, Emmanuelle Le Chatelier, Nicolas Pons, Nicolas Maziers, Florence Thirion, Franck Gauthier, Florian Plaza Oñate, Jean-Pierre Furet and 8 more

Abstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Intestinal microbiota and arthritis.EULAR rheumatology open · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Magali BerlandUniversité Paris-Saclay and MetaGenoPolis, INRAE, Jouy-en-Josas, France.ORCID 0000-0002-6762-5350
Victoria MeslierUniversité Paris-Saclay and MetaGenoPolis, INRAE, Jouy-en-Josas, France.
Samar Berreira IbraimUniversité Paris-Saclay and MetaGenoPolis, INRAE, Jouy-en-Josas, France.
Emmanuelle Le ChatelierUniversité Paris-Saclay and MetaGenoPolis, INRAE, Jouy-en-Josas, France.
Nicolas PonsUniversité Paris-Saclay and MetaGenoPolis, INRAE, Jouy-en-Josas, France.
Nicolas MaziersUniversité Paris-Saclay and MetaGenoPolis, INRAE, Jouy-en-Josas, France.
Florence ThirionUniversité Paris-Saclay and MetaGenoPolis, INRAE, Jouy-en-Josas, France.
Franck GauthierUniversité Paris-Saclay and MetaGenoPolis, INRAE, Jouy-en-Josas, France.
Florian Plaza OñateUniversité Paris-Saclay and MetaGenoPolis, INRAE, Jouy-en-Josas, France.
Jean-Pierre FuretAgroParisTech, Université Paris-Saclay and the Micalis Institute, INRAE, Jouy-en-Josas, France, and Paris Center for Microbiome Medicine (PaCeMM) FHU, Paris, France.
Ariane LeboimeService de Rhumatologie, Hôpital Ambroise Paré, AP-HP, Boulogne, France.
Roula Said-NahalService de Rhumatologie, Hôpital Ambroise Paré, AP-HP, Boulogne, France.
Florence LevenezUniversité Paris-Saclay and MetaGenoPolis, INRAE, Jouy-en-Josas, France.
Nathalie GalleronUniversité Paris-Saclay and MetaGenoPolis, INRAE, Jouy-en-Josas, France.
Benoît QuinquisUniversité Paris-Saclay and MetaGenoPolis, INRAE, Jouy-en-Josas, France.
Philippe LangellaAgroParisTech, Université Paris-Saclay and the Micalis Institute, INRAE, Jouy-en-Josas, France, and Paris Center for Microbiome Medicine (PaCeMM) FHU, Paris, France.
Stanislav Dusko EhrlichUniversité Paris-Saclay, MetaGenoPolis, INRAE, Jouy-en-Josas, France, and the Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK, and Paris Center for Microbiome Medicine (PaCeMM) FHU, Paris, France.
Maxime BrebanService de Rhumatologie, Hôpital Ambroise Paré, AP-HP, Boulogne, France, Infection & Inflammation, UMR 1173, Inserm, Université de Versailles-Paris-Saclay, Montigny-le-Bretonneux, France, and Laboratoire d'Excellence Inflamex, Université Paris Descartes, Sorbonne Paris Cité, and Paris Center for Microbiome Medicine (PaCeMM) FHU, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveGut microbiome dysbiosis has previously been reported in spondyloarthritis (SpA) patients and could be critically involved in the pathogenesis of this disorder. The objectives of this study were to further characterize the microbiota structure in SpA patients and to investigate the relationship between dysbiosis and disease activity in light of the putative influence of the genetic background.

methodsShotgun sequencing was performed on fecal DNA isolated from stool samples from 2 groups of adult volunteers: SpA patients (n = 102) and healthy controls (n = 63). A subset of the healthy controls comprised the age-matched siblings of patients whose HLA-B27 status was known. Changes in gut microbiota composition were assessed based on species diversity, enterotypes, and taxonomic and functional differences.

resultsDysbiosis was confirmed in SpA patients as compared to healthy controls. The restriction of microbiota diversity was detected in patients with the most active disease, and the abundance of several bacterial species was correlated with Bath Ankylosing Spondylitis Disease Activity Index score. Among healthy controls, significant differences in microbiota composition were also detected between the HLA-B27-positive and the HLA-B27-negative siblings of SpA patients. We highlighted a decreased abundance of several species of bacteria in SpA patients, especially those bacteria belonging to the Clostridiales order. Among the few species of bacteria showing increased abundance, Ruminococcus gnavus was one of the top differentiating species.

conclusionThese findings reveal that genetic background and level of disease activity are likely to influence the composition of the gut microbiota of patients with SpA. It may be appropriate for further research on chronic arthritis to focus on these key parameters.

Indexed as

Gastrointestinal MicrobiomeMicrobiotaSpondylarthritisAdultDysbiosisHLA-B27 AntigenHumansHLA-B27 Antigen

Identifiers

PMID35818337
PMCPMC10099252

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.